Latest filings (excl ownership)
8-K
Bio-Rad Announces Life Science Group Management Changes
26 Apr 24
8-K
Departure of Directors or Certain Officers
10 Apr 24
DEF 14A
Definitive proxy
27 Mar 24
ARS
2023 FY
Annual report to shareholders
27 Mar 24
8-K
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
20 Mar 24
8-K
Regulation FD Disclosure
21 Feb 24
10-K
2023 FY
Annual report
16 Feb 24
8-K
Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
15 Feb 24
8-K
Entry into a Material Definitive Agreement
14 Feb 24
8-K
Departure of Directors or Certain Officers
7 Dec 23
10-Q
2023 Q3
Quarterly report
27 Oct 23
8-K
Bio-Rad Reports Third-Quarter 2023 Financial Results
26 Oct 23
8-K
Departure of Directors or Certain Officers
17 Oct 23
8-K
Departure of Directors or Certain Officers
25 Aug 23
10-Q
2023 Q2
Quarterly report
4 Aug 23
8-K
Bio-Rad Reports Second-Quarter 2023 Financial Results
3 Aug 23
8-K
Bio-Rad Announces New Share Repurchase Program
20 Jul 23
8-K
Regulation FD Disclosure
5 Jun 23
SD
Conflict minerals disclosure
24 May 23
10-Q
2023 Q1
Quarterly report
5 May 23
8-K
Bio-Rad Reports First-Quarter 2023 Financial Results
4 May 23
8-K
Submission of Matters to a Vote of Security Holders
1 May 23
ARS
2022 FY
Annual report to shareholders
29 Mar 23
DEF 14A
Definitive proxy
29 Mar 23
8-K
Regulation FD Disclosure
23 Feb 23
10-K
2022 FY
Annual report
17 Feb 23
8-K
Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results
16 Feb 23
8-K
Regulation FD Disclosure
10 Jan 23
UPLOAD
Letter from SEC
16 Dec 22
CORRESP
Correspondence with SEC
14 Dec 22
UPLOAD
Letter from SEC
2 Dec 22
8-K
Regulation FD Disclosure
8 Nov 22
10-Q
2022 Q3
Quarterly report
28 Oct 22
8-K
Bio-Rad Reports Third-Quarter 2022 Financial Results
27 Oct 22
CORRESP
Correspondence with SEC
11 Aug 22
10-Q
2022 Q2
Quarterly report
29 Jul 22
UPLOAD
Letter from SEC
29 Jul 22
8-K
Bio-Rad Reports Second-Quarter 2022 Financial Results
28 Jul 22
SD
Conflict minerals disclosure
25 May 22
8-K
Regulation FD Disclosure
18 May 22
Latest ownership filings
SC 13G
Oncocyte Corp
22 Apr 24
3
Roop Kalyan Lakkaraju
17 Apr 24
4
Andrew J. Last
12 Mar 24
4
SIMON MAY
12 Mar 24
4
COLLEEN COREY
12 Mar 24
4
TIMOTHY S ERNST
12 Mar 24
4
SEDAT EVRAN
12 Mar 24
4
NORMAN D SCHWARTZ
12 Mar 24
4
Michael Crowley
12 Mar 24
SC 13G/A
VANGUARD GROUP INC
11 Mar 24
4
TIMOTHY S ERNST
29 Feb 24
4
Michael Crowley
28 Feb 24
144
Notice of proposed sale of securities
28 Feb 24
144
Notice of proposed sale of securities
27 Feb 24
144
Notice of proposed sale of securities
27 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
BlackRock Inc.
29 Jan 24
4
DARA WRIGHT
19 Dec 23
4
STEVEN D SCHWARTZ
14 Dec 23
4
DARA WRIGHT
12 Dec 23
144
Notice of proposed sale of securities
12 Dec 23
4
Schwartz Allison
8 Dec 23
4
NORMAN D SCHWARTZ
7 Dec 23
4
ALICE N SCHWARTZ
7 Dec 23
4
Michael Crowley
28 Nov 23
144
Notice of proposed sale of securities
28 Nov 23
144
Notice of proposed sale of securities
28 Nov 23
4
NORMAN D SCHWARTZ
2 Nov 23
4
SEDAT EVRAN
23 Oct 23
3
TANIA DEVILLIERS
27 Sep 23
3
SEDAT EVRAN
14 Sep 23
4
Andrew J. Last
6 Sep 23
4
DARA WRIGHT
6 Sep 23
4
TIMOTHY S ERNST
6 Sep 23
4
AJIT RAMALINGAM
6 Sep 23
4
Michael Crowley
6 Sep 23
4
Ilan Daskal
6 Sep 23
4
Schwartz Allison
6 Sep 23
4
Diane Dahowski
6 Sep 23
4
SIMON MAY
6 Sep 23